Verano Holdings (VRNO) Goodwill & Intangibles (2021 - 2026)
Verano Holdings' (VRNO) quarterly Goodwill & Intangibles came in at $725.6 million in Q1 2026, down 24.8% year-on-year from $964.9 million in Q1 2025, and down 1.96% on a QoQ basis from $740.1 million in Q4 2025.
Verano Holdings (VRNO) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Goodwill & Intangibles data on file, last reported at $725.6 million in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles fell 24.8% year-over-year to $725.6 million in Q1 2026; TTM through Mar 2026 was $725.6 million, a 24.8% decrease from a year earlier, with the FY2025 full-year figure at $740.1 million, down 24.5% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $725.6 million, down from $740.1 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for VRNO reached as high as $1.7 billion in Q2 2022 and fell as low as $725.6 million in Q1 2026.
- Historically, Goodwill & Intangibles has averaged $1.2 billion across 5 years, with a median of $1.3 billion in 2024.
- Across the five-year window, Goodwill & Intangibles surged 489.05% in 2022 and slipped 28.34% in 2025, its largest moves.
- Year by year, Goodwill & Intangibles stood at $1.4 billion in 2022, then slipped by 9.13% to $1.3 billion in 2023, then retreated by 25.6% to $980.2 million in 2024, then dropped by 24.5% to $740.1 million in 2025, then declined by 1.96% to $725.6 million in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $725.6 million in Q1 2026, $740.1 million in Q4 2025, and $931.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 725.58 Mn |
| Dec 31, 2025 | 740.10 Mn |
| Sep 30, 2025 | 931.37 Mn |
| Jun 30, 2025 | 948.12 Mn |
| Mar 31, 2025 | 964.86 Mn |
| Dec 31, 2024 | 980.24 Mn |
| Sep 30, 2024 | 1.30 Bn |
| Jun 30, 2024 | 1.27 Bn |
| Mar 31, 2024 | 1.29 Bn |
| Dec 31, 2023 | 1.32 Bn |
| Sep 30, 2023 | 1.38 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.43 Bn |
| Dec 31, 2022 | 1.45 Bn |
| Sep 30, 2022 | 1.71 Bn |
| Jun 30, 2022 | 1.72 Bn |
| Dec 31, 2021 | 1.75 Bn |
| Sep 30, 2021 | 289.79 Mn |
| Jun 30, 2021 | 380.46 Mn |